What is the role of FDG-PET in thoracic oncology in 2010?
18F-Fluorodeoxyglucose-Positron Emission Tomography (FGD-PET) has been considered to have a major impact on the management of lung malignancies since the beginning of this century. Its value has been demonstrated by many publications, meta-analysis and European/American/Japanese recommendations. PET...
Gespeichert in:
| Veröffentlicht in: | Revue de pneumologie clinique 2010-09, Vol.66 (4), p.221-238 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | fre |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 238 |
|---|---|
| container_issue | 4 |
| container_start_page | 221 |
| container_title | Revue de pneumologie clinique |
| container_volume | 66 |
| creator | Vaylet, F Margery, J Bonardel, G Le Floch, H Rivière, F Gontier, E Ngampolo, I Mairovitz, A Marotel, C Foehrenbach, H |
| description | 18F-Fluorodeoxyglucose-Positron Emission Tomography (FGD-PET) has been considered to have a major impact on the management of lung malignancies since the beginning of this century. Its value has been demonstrated by many publications, meta-analysis and European/American/Japanese recommendations. PET combined with computed tomography has provided useful information regarding the diagnosis and staging of lung cancer and allows for the delivery of adaptive radiotherapy. In its more common uses, PET has been shown to be cost-effective. With the widespread use of new radiotracers, PET will play an increasing role in the evaluation of response to treatment. |
| doi_str_mv | 10.1016/j.pneumo.2010.07.010 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_757463818</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>757463818</sourcerecordid><originalsourceid>FETCH-LOGICAL-p140t-f786681ddc470a4b223e9556afa122e32ee855fb38ac885d28ef17c4d151ffb03</originalsourceid><addsrcrecordid>eNo1j71OwzAYRT2AaCm8AULemBL8-T8TQqUtSJVgKGKMHMemqZI4xMnQtycVZbrS0dG9ugjdAUmBgHw8pF3rxiaklEyIqHSKCzQnSkKiOagZuo7xQAgFReAKzSjJGAPJ5yj72psBVxEPe4f7UDscPF6_bJKP1Q5X7YRDb2xlcWhtqMP38QRPK0836NKbOrrbcy7Q53q1W74m2_fN2_J5m3TAyZB4paXUUJaWK2J4QSlzmRDSeAOUOkad00L4gmljtRYl1c6DsrwEAd4XhC3Qw19v14ef0cUhb6poXV2b1oUx5kooLpkGPZn3Z3MsGlfmXV81pj_m_2_ZLyMdU60</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>757463818</pqid></control><display><type>article</type><title>What is the role of FDG-PET in thoracic oncology in 2010?</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Vaylet, F ; Margery, J ; Bonardel, G ; Le Floch, H ; Rivière, F ; Gontier, E ; Ngampolo, I ; Mairovitz, A ; Marotel, C ; Foehrenbach, H</creator><creatorcontrib>Vaylet, F ; Margery, J ; Bonardel, G ; Le Floch, H ; Rivière, F ; Gontier, E ; Ngampolo, I ; Mairovitz, A ; Marotel, C ; Foehrenbach, H</creatorcontrib><description>18F-Fluorodeoxyglucose-Positron Emission Tomography (FGD-PET) has been considered to have a major impact on the management of lung malignancies since the beginning of this century. Its value has been demonstrated by many publications, meta-analysis and European/American/Japanese recommendations. PET combined with computed tomography has provided useful information regarding the diagnosis and staging of lung cancer and allows for the delivery of adaptive radiotherapy. In its more common uses, PET has been shown to be cost-effective. With the widespread use of new radiotracers, PET will play an increasing role in the evaluation of response to treatment.</description><identifier>ISSN: 0761-8417</identifier><identifier>DOI: 10.1016/j.pneumo.2010.07.010</identifier><identifier>PMID: 20933164</identifier><language>fre</language><publisher>France</publisher><subject>Fluorodeoxyglucose F18 ; Humans ; Lung Neoplasms - diagnostic imaging ; Lung Neoplasms - pathology ; Neoplasm Staging ; Positron-Emission Tomography - methods ; Predictive Value of Tests ; Radiopharmaceuticals ; Sensitivity and Specificity ; Tomography, X-Ray Computed</subject><ispartof>Revue de pneumologie clinique, 2010-09, Vol.66 (4), p.221-238</ispartof><rights>Copyright © 2010. Published by Elsevier Masson SAS.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20933164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vaylet, F</creatorcontrib><creatorcontrib>Margery, J</creatorcontrib><creatorcontrib>Bonardel, G</creatorcontrib><creatorcontrib>Le Floch, H</creatorcontrib><creatorcontrib>Rivière, F</creatorcontrib><creatorcontrib>Gontier, E</creatorcontrib><creatorcontrib>Ngampolo, I</creatorcontrib><creatorcontrib>Mairovitz, A</creatorcontrib><creatorcontrib>Marotel, C</creatorcontrib><creatorcontrib>Foehrenbach, H</creatorcontrib><title>What is the role of FDG-PET in thoracic oncology in 2010?</title><title>Revue de pneumologie clinique</title><addtitle>Rev Pneumol Clin</addtitle><description>18F-Fluorodeoxyglucose-Positron Emission Tomography (FGD-PET) has been considered to have a major impact on the management of lung malignancies since the beginning of this century. Its value has been demonstrated by many publications, meta-analysis and European/American/Japanese recommendations. PET combined with computed tomography has provided useful information regarding the diagnosis and staging of lung cancer and allows for the delivery of adaptive radiotherapy. In its more common uses, PET has been shown to be cost-effective. With the widespread use of new radiotracers, PET will play an increasing role in the evaluation of response to treatment.</description><subject>Fluorodeoxyglucose F18</subject><subject>Humans</subject><subject>Lung Neoplasms - diagnostic imaging</subject><subject>Lung Neoplasms - pathology</subject><subject>Neoplasm Staging</subject><subject>Positron-Emission Tomography - methods</subject><subject>Predictive Value of Tests</subject><subject>Radiopharmaceuticals</subject><subject>Sensitivity and Specificity</subject><subject>Tomography, X-Ray Computed</subject><issn>0761-8417</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j71OwzAYRT2AaCm8AULemBL8-T8TQqUtSJVgKGKMHMemqZI4xMnQtycVZbrS0dG9ugjdAUmBgHw8pF3rxiaklEyIqHSKCzQnSkKiOagZuo7xQAgFReAKzSjJGAPJ5yj72psBVxEPe4f7UDscPF6_bJKP1Q5X7YRDb2xlcWhtqMP38QRPK0836NKbOrrbcy7Q53q1W74m2_fN2_J5m3TAyZB4paXUUJaWK2J4QSlzmRDSeAOUOkad00L4gmljtRYl1c6DsrwEAd4XhC3Qw19v14ef0cUhb6poXV2b1oUx5kooLpkGPZn3Z3MsGlfmXV81pj_m_2_ZLyMdU60</recordid><startdate>201009</startdate><enddate>201009</enddate><creator>Vaylet, F</creator><creator>Margery, J</creator><creator>Bonardel, G</creator><creator>Le Floch, H</creator><creator>Rivière, F</creator><creator>Gontier, E</creator><creator>Ngampolo, I</creator><creator>Mairovitz, A</creator><creator>Marotel, C</creator><creator>Foehrenbach, H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201009</creationdate><title>What is the role of FDG-PET in thoracic oncology in 2010?</title><author>Vaylet, F ; Margery, J ; Bonardel, G ; Le Floch, H ; Rivière, F ; Gontier, E ; Ngampolo, I ; Mairovitz, A ; Marotel, C ; Foehrenbach, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p140t-f786681ddc470a4b223e9556afa122e32ee855fb38ac885d28ef17c4d151ffb03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2010</creationdate><topic>Fluorodeoxyglucose F18</topic><topic>Humans</topic><topic>Lung Neoplasms - diagnostic imaging</topic><topic>Lung Neoplasms - pathology</topic><topic>Neoplasm Staging</topic><topic>Positron-Emission Tomography - methods</topic><topic>Predictive Value of Tests</topic><topic>Radiopharmaceuticals</topic><topic>Sensitivity and Specificity</topic><topic>Tomography, X-Ray Computed</topic><toplevel>online_resources</toplevel><creatorcontrib>Vaylet, F</creatorcontrib><creatorcontrib>Margery, J</creatorcontrib><creatorcontrib>Bonardel, G</creatorcontrib><creatorcontrib>Le Floch, H</creatorcontrib><creatorcontrib>Rivière, F</creatorcontrib><creatorcontrib>Gontier, E</creatorcontrib><creatorcontrib>Ngampolo, I</creatorcontrib><creatorcontrib>Mairovitz, A</creatorcontrib><creatorcontrib>Marotel, C</creatorcontrib><creatorcontrib>Foehrenbach, H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Revue de pneumologie clinique</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vaylet, F</au><au>Margery, J</au><au>Bonardel, G</au><au>Le Floch, H</au><au>Rivière, F</au><au>Gontier, E</au><au>Ngampolo, I</au><au>Mairovitz, A</au><au>Marotel, C</au><au>Foehrenbach, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>What is the role of FDG-PET in thoracic oncology in 2010?</atitle><jtitle>Revue de pneumologie clinique</jtitle><addtitle>Rev Pneumol Clin</addtitle><date>2010-09</date><risdate>2010</risdate><volume>66</volume><issue>4</issue><spage>221</spage><epage>238</epage><pages>221-238</pages><issn>0761-8417</issn><abstract>18F-Fluorodeoxyglucose-Positron Emission Tomography (FGD-PET) has been considered to have a major impact on the management of lung malignancies since the beginning of this century. Its value has been demonstrated by many publications, meta-analysis and European/American/Japanese recommendations. PET combined with computed tomography has provided useful information regarding the diagnosis and staging of lung cancer and allows for the delivery of adaptive radiotherapy. In its more common uses, PET has been shown to be cost-effective. With the widespread use of new radiotracers, PET will play an increasing role in the evaluation of response to treatment.</abstract><cop>France</cop><pmid>20933164</pmid><doi>10.1016/j.pneumo.2010.07.010</doi><tpages>18</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0761-8417 |
| ispartof | Revue de pneumologie clinique, 2010-09, Vol.66 (4), p.221-238 |
| issn | 0761-8417 |
| language | fre |
| recordid | cdi_proquest_miscellaneous_757463818 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Fluorodeoxyglucose F18 Humans Lung Neoplasms - diagnostic imaging Lung Neoplasms - pathology Neoplasm Staging Positron-Emission Tomography - methods Predictive Value of Tests Radiopharmaceuticals Sensitivity and Specificity Tomography, X-Ray Computed |
| title | What is the role of FDG-PET in thoracic oncology in 2010? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T16%3A41%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=What%20is%20the%20role%20of%20FDG-PET%20in%20thoracic%20oncology%20in%202010?&rft.jtitle=Revue%20de%20pneumologie%20clinique&rft.au=Vaylet,%20F&rft.date=2010-09&rft.volume=66&rft.issue=4&rft.spage=221&rft.epage=238&rft.pages=221-238&rft.issn=0761-8417&rft_id=info:doi/10.1016/j.pneumo.2010.07.010&rft_dat=%3Cproquest_pubme%3E757463818%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=757463818&rft_id=info:pmid/20933164&rfr_iscdi=true |